Aim and Scope

Focus and Scope

European Journal of Molecular & Clinical Medicine (EJMCM) is an open access online journal publishing high quality manuscripts covering all aspects of molecular and clinical medicine. Submitted manuscripts are peer reviewed and selection is based on scientific excellence, distinctive contribution to knowledge and importance to the field.

Molecular Medicine Section: Special consideration will be given to novel findings generated in cellular and molecular biology, genetics, stem cell biology, microbiology, immunology and the omics disciplines. In addition, quality manuscripts describing novel developments in the field of biomarkers, disease modelling, large data set mining will be considered for publication.

Clinical Medicine Section: Special consideration will be given to high quality clinical studies and case reports from all clinical specialties. Manuscripts should provide new insight and contribute to advance medical knowledge.

Publication Frequency

The journal is published online as a continuous volume and issue throughout the year. Articles are made available as soon as they are ready to ensure that there are no unnecessary delays in getting content publically available.

Special collections of articles are welcomed and will be published as part of the normal issue, but also within a separate collection page.

Open Access Policy

This journal operates at a Gold Standard level of open access. It provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. It complies with open access funding body policies and also encourages the publication of research data. There is no embargo on the journal’s publications. Submission and acceptance dates, along with publication dates, are made available on the PDF format for each paper.

Authors of articles published remain the copyright holders and grant third parties the right to use, reproduce, and share the article according to the Creative Commons license agreement.

Authors are encouraged to publish their data in recommended repositories. For a list of generic and subject specific repositories that meet our peer review criteria, see here.

Archiving Policy

The journal’s publisher focuses on making content discoverable and accessible through indexing services. Content is also archived around the world to ensure long-term availability.

To ensure permanency of all publications, this journal also utilises CLOCKSS, and LOCKSS archiving systems to create permanent archives for the purposes of preservation and restoration.

Articles that are NIH funded require the author to deposit the details in pubmed. Information on how to do this can be found here.

If the journal is not indexed by your preferred service, please contact us or alternatively by making an indexing request directly with the service.

Advertisement policy

The journal only displays advertisements that are of relevance to its scope and will be of interest to the readership (e.g. upcoming conferences). All advertising space is provided free of charge and the editor and publisher have the right to decline or withdraw adverts at any point.

If you wish to propose a potential advert then please contact the editorial team. All advert images will have to be provided to the publisher.

Disclaimer

No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a result of any actual or alleged libellous statements, infringement of intellectual property or privacy rights, or products liability.

About Journal

Distinctions: The most widely read, cited, and known Molecular & Clinical Medicine journal and website is well browsed with all the articles published. More than 30,000 readers per month

ISSN: 2515-8260; Frequency: Rapid at a time publication (6 issues/year)

Indexed and Abstracted: Scopus, CrossRef, JISC KB+, SHERPA RoMEO, Cengage Learning, Directory of Open Access Journals (DOAJ), and Google Scholar. To ensure permanency of all publications, this journal also utilizes CLOCKSS, and LOCKSS archiving systems to create permanent archives for the purposes of preservation and restoration. In addition, all journal contents are available for harvesting via OAI-PMH.

Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.

Open Access Journal: European Journal of Molecular & Clinical Medicine is an open-access journal, which allows authors to fund their article to be open access from publication.